Spyre Therapeutics Stock Investor Sentiment
| SYRE Stock | 22.27 0.37 1.69% |
About 50% of Spyre Therapeutics' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Spyre Therapeutics suggests that some traders are interested. The current market sentiment, together with Spyre Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Spyre Therapeutics stock news signals to limit their universe of possible portfolio assets.
Spyre |
Spyre Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Spyre Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Spyre Therapeutics that are available to investors today. That information is available publicly through Spyre media outlets and privately through word of mouth or via Spyre internal channels. However, regardless of the origin, that massive amount of Spyre data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Spyre Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Spyre Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Spyre Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Spyre Therapeutics alpha.
Spyre Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 6700 shares by Albers Jeffrey W. of Spyre Therapeutics at 36.7631 subject to Rule 16b-3 | 11/06/2024 |
2 | FMR LLC Acquires Additional Shares in Spyre Therapeutics Inc | 11/13/2024 |
3 | Spyre Therapeutics revises net loss per share calculations | 11/18/2024 |
4 | Spyre Therapeutics Announces Pricing of 200 Million Public Offering of Common Stock | 11/19/2024 |
5 | Spyre Therapeutics, Inc. Shares Sold by Braidwell LP | 11/29/2024 |
6 | SPYRE ALERT Bragar Eagel Squire, P.C. is Investigating Spyre Therapeutics, Inc. ... | 12/04/2024 |
7 | Spyre Therapeutics Different Name, Same Tune - Seeking Alpha | 12/12/2024 |
8 | Spyre Therapeutics Awards Key Employee Stock Options at 24.35 with 10-Year Term - StockTitan | 01/03/2025 |
9 | Acquisition by Henderson Michael Thomas of 105379 shares of Spyre Therapeutics subject to Rule 16b-3 | 01/10/2025 |
10 | Acquisition by King-jones Heidy of 95500 shares of Spyre Therapeutics at 21.66 subject to Rule 16b-3 | 01/15/2025 |
11 | Spyre Therapeutics Shares Up 9.4 percent Time to Buy | 01/21/2025 |
Complementary Tools for Spyre Stock analysis
When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |